HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 279, Issue 3, 2135-2146, January 16, 2004

This Article Full Text Full Text (PDF) All Versions of this Article: 279/3/2135    most recent M309000200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nguyen, V. T. Articles by Grando, S. A. Search for Related Content PubMed PubMed Citation Articles by Nguyen, V. T. Articles by Grando, S. A. Social Bookmarking                      What's this?

Pemphigus Vulgaris IgG and Methylprednisolone Exhibit Reciprocal Effects on Keratinocytes^*

Vu Thuong Nguyen, Juan Arredondo, Alexander I. Chernyavsky, Yasuo Kitajima, Mark Pittelkow¶, and Sergei A. Grando||

From the Department of Dermatology, University of California School of Medicine, Davis, California 95616, the Department of Dermatology, Gifu University, Gifu City 500-8705, Japan, and the ^¶Department of Dermatology, Mayo Clinic, Rochester, Minnesota 55905

Pemphigus vulgaris (PV) is a life-threatening autoimmune disease of skin adhesion associated with IgG autoantibodies against keratinocytes (KC). Treatment of PV with systemic corticosteroids is life-saving, but the mechanism of the therapeutic action has not been fully understood. We have developed an animal model that demonstrates that methylprednisolone (MP) can block PV IgG-induced acantholysis, decreasing the extent of keratinocyte detachment in the epidermis of 3–5-day-old nude mice from 77.5 ± 0.6 to 24.1 ± 1.5% (p < 0.05). We hypothesized that in addition to immunosuppression, MP may exhibit direct anti-acantholytic effects in epidermis, and we compared the effects of PV IgG and MP on KC. The use of DNA microarray showed that PV IgG down-regulated and MP up-regulated expression of the genes encoding keratinocyte adhesion molecules, antigen-processing proteins, regulators of cell cycle and apoptosis, differentiation markers, Na⁺,K⁺-ATPase, protein kinases and phosphatases, and serine proteases and their inhibitors. Overall, PV IgG decreased transcription of 198 genes and increased transcription of 31 genes. MP decreased transcription of 14 genes and increased transcription of 818 genes. Specific effects of PV IgG and MP on keratinocyte adhesion molecules were further investigated by Western blot and immunofluorescence assays. By immunoblotting, MP increased the protein levels of E-cadherin and desmogleins 1 and 3 by 300, 180, and 40%, respectively. Specific staining of KC for E-cadherin and desmogleins 1 and 3 increased by 235, 228, and 148%, respectively. In addition, PV IgG increased the level of phosphorylation of E-cadherin by 42%, -catenin by 37%, -catenin by 136%, and desmoglein 3 by 300%, whereas pretreatment with 0.25 mM MP abolished phosphorylation of these adhesion molecules. These results suggested that therapeutic effects of MP in PV include both the up-regulated synthesis and post-translational modification of the keratinocyte adhesion molecules.

Received for publication, August 14, 2003 , and in revised form, November 4, 2003.

^* This work was supported in part by a research grant from the Robert Leet and Clara Guthrie Patterson Trust (to S. A. G.) and the International Pemphigus Research Fund. This work was presented in part at the 62nd and 63rd Annual Meetings of the Society for Investigative Dermatology and published as abstracts (Nguyen, V. T., and Grando, S. A. (2001) J. Investig. Dermatol. 117, 543 (Abstr. 919); Nguyen, V. T., Arredondo, J., Chernyavsky, A., Pittelkow, M. R., Kitajima, Y., and Grando, S. A. (2002) J. Investig. Dermatol. 119, 227 (Abstr. 116). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

^|| To whom correspondence should be addressed: 4860 Y St., Ste. 3400, Sacramento, CA 95817. Tel.: 916-734-6057; Fax: 916-734-6793; E-mail: sagrando{at}ucdavis.edu.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Lanza, N. Cirillo, R. Rossiello, M. Rienzo, L. Cutillo, A. Casamassimi, F. de Nigris, C. Schiano, L. Rossiello, F. Femiano, et al. Evidence of Key Role of Cdk2 Overexpression in Pemphigus Vulgaris J. Biol. Chem., March 28, 2008; 283(13): 8736 - 8745. [Abstract] [Full Text] [PDF]

				A. I. Chernyavsky, J. Arredondo, T. Piser, E. Karlsson, and S. A. Grando Differential Coupling of M1 Muscarinic and {alpha}7 Nicotinic Receptors to Inhibition of Pemphigus Acantholysis J. Biol. Chem., February 8, 2008; 283(6): 3401 - 3408. [Abstract] [Full Text] [PDF]

				A. I. Chernyavsky, J. Arredondo, Y. Kitajima, M. Sato-Nagai, and S. A. Grando Desmoglein Versus Non-desmoglein Signaling in Pemphigus Acantholysis: CHARACTERIZATION OF NOVEL SIGNALING PATHWAYS DOWNSTREAM OF PEMPHIGUS VULGARIS ANTIGENS J. Biol. Chem., May 4, 2007; 282(18): 13804 - 13812. [Abstract] [Full Text] [PDF]

				P. Berkowitz, P. Hu, S. Warren, Z. Liu, L. A. Diaz, and D. S. Rubenstein p38MAPK inhibition prevents disease in pemphigus vulgaris mice PNAS, August 22, 2006; 103(34): 12855 - 12860. [Abstract] [Full Text] [PDF]

				C. C. Calkins, S. V. Setzer, J. M. Jennings, S. Summers, K. Tsunoda, M. Amagai, and A. P. Kowalczyk Desmoglein Endocytosis and Desmosome Disassembly Are Coordinated Responses to Pemphigus Autoantibodies J. Biol. Chem., March 17, 2006; 281(11): 7623 - 7634. [Abstract] [Full Text] [PDF]

				M. D. Kottke, E. Delva, and A. P. Kowalczyk The desmosome: cell science lessons from human diseases. J. Cell Sci., March 1, 2006; 119(Pt 5): 797 - 806. [Abstract] [Full Text] [PDF]

				J. Arredondo, A. I. Chernyavsky, A. Karaouni, and S. A. Grando Novel Mechanisms of Target Cell Death and Survival and of Therapeutic Action of IVIg in Pemphigus Am. J. Pathol., December 1, 2005; 167(6): 1531 - 1544. [Abstract] [Full Text] [PDF]

				M. FRUSIC-ZLOTKIN, R. PERGAMENTZ, B. MICHEL, M. DAVID, D. MIMOUNI, F. BREGEGERE, and Y. MILNER The Interaction of Pemphigus Autoimmunoglobulins with Epidermal Cells: Activation of the Fas Apoptotic Pathway and the Use of Caspase Activity for Pathogenicity Tests of Pemphigus Patients Ann. N.Y. Acad. Sci., June 1, 2005; 1050(1): 371 - 379. [Abstract] [Full Text] [PDF]

				R. Tomic, C. C. Lassiter, J. D. Ritzenthaler, H. N. Rivera, and J. Roman Anti-Tissue Remodeling Effects of Corticosteroids: Fluticasone Propionate Inhibits Fibronectin Expression in Fibroblasts Chest, January 1, 2005; 127(1): 257 - 265. [Abstract] [Full Text] [PDF]

				V. T. Nguyen, J. Arredondo, A. I. Chernyavsky, M. R. Pittelkow, Y. Kitajima, and S. A. Grando Pemphigus Vulgaris Acantholysis Ameliorated by Cholinergic Agonists Arch Dermatol, March 1, 2004; 140(3): 327 - 334. [Abstract] [Full Text] [PDF]